Paragon Associates & Paragon Associates II Joint Venture’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
Other funds holding HOLX
Paragon Associates & Paragon Associates II Joint Venture's HOLX Position: Q1 2023 in Review
Paragon Associates & Paragon Associates II Joint Venture sold out of Hologic (HOLX) in Q1 2023, closing a stake of 10,000 shares — an estimated $748K sold.
Paragon Associates & Paragon Associates II Joint Venture first reported a position in HOLX in Q4 2022 and held it in 1 quarter. The position peaked at $748K in Q4 2022. 708 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.
- Paragon Associates & Paragon Associates II Joint Venture reported no remaining Hologic position as of Q1 2023 after selling out during the quarter.
- Paragon Associates & Paragon Associates II Joint Venture sold 10,000 Hologic shares in Q1 2023, an estimated $748K.
- Paragon Associates & Paragon Associates II Joint Venture first reported a position in Hologic in Q4 2022 and held it in 1 quarter.
- Paragon Associates & Paragon Associates II Joint Venture's Hologic position peaked at $748K in Q4 2022.
- 708 funds tracked by Wall St. Rank held Hologic as of Q1 2023.
Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q1 2023, filed 15 May 2023.